✦ LIBER ✦

Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson’s Disease

✍ Scribed by Huang, Liang; Shimoji, Mika; Wang, Juan; Shah, Salim; Kamila, Sukanta; Biehl, Edward R.; Lim, Seung; Chang, Allison; Maguire-Zeiss, Kathleen A.; Su, Xiaomin; Federoff, Howard J.

Book ID: 120835924
Publisher: Springer-Verlag
Year: 2013
Tongue: English
Weight: 703 KB
Volume: 10
Category: Article
ISSN: 1933-7213
DOI: 10.1007/s13311-013-0208-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Leucine-rich repeat kinase 2 (LRRK2) as

Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease

✍ Byoung Dae Lee; Valina L. Dawson; Ted M. Dawson 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 487 KB

The role of leucine-rich repeat kinase 2

The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

✍ Cookson, Mark R. 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 358 KB

Genetic characteristics of leucine-rich

Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease

✍ Soraya Bardien; Suzanne Lesage; Alexis Brice; Jonathan Carr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 497 KB

Curcumin exposure induces expression of

Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells

✍ Miguel A. Ortiz-Ortiz; José M. Morán; Luz M. Ruiz-Mesa; Mireia Niso-Santano; Jos 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 399 KB

Leucine-rich repeat kinase 2 (LRRK2): A

Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease

✍ Payal N. Gandhi; Shu G. Chen; Amy L. Wilson-Delfosse 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years. Mutations in the gene encoding leucine‐rich repeat kinase‐2 (__LRRK2__) have recently been linked to autosomal dominant, late‐onset PD that is cl

3.049 LEVODOPA-INDUCED DYSKINESIA IN PAR

3.049 LEVODOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE PATIENTS CARRYING THE LEUCINE-RICH REPEAT KINASE 2 (LRRK2) G2019S MUTATION

✍ G. Yahalom; N. Kaplan; A. Vituri; O.S. Cohen; R. Inzelberg; H. Strauss; E. Kozlo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB